The global acute respiratory distress syndrome market was valued at approximately USD 1.4 billion in 2024 and is expected to grow to nearly USD 2.2 billion by 2032. This growth represents a compound annual growth rate (CAGR) of around 5.9%. Factors like the rising incidence of sepsis and p